Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEXUS-BIOPHARMA-INC-120796313/news/Nexus-BioPharma-Inc-to-License-TransChem-s-Transition-State-Chemistry-Technology-for-Kinase-Inhibi-35316371/?utm_source=whatsapp&utm_medium=social&utm_campaign=share